Maya Hites
About
Maya Hites is a scholar working on Pharmacology, Epidemiology and Infectious Diseases.
According to data from OpenAlex, Maya Hites has authored 77 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pharmacology, 35 papers in Epidemiology and 26 papers in Infectious Diseases. Recurrent topics in Maya Hites's work include Antibiotics Pharmacokinetics and Efficacy (35 papers), Antibiotic Use and Resistance (16 papers) and Pneumonia and Respiratory Infections (12 papers). Maya Hites is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (35 papers), Antibiotic Use and Resistance (16 papers) and Pneumonia and Respiratory Infections (12 papers). Maya Hites collaborates with scholars based in Belgium, France and Australia. Maya Hites's co-authors include Fabio Silvio Taccone, Frédéric Cotton, Frédérique Jacobs, Jean‐Louis Vincent, Fleur Wolff, Jason A. Roberts, F. Jacobs, Marjorie Beumier, Jeffrey Lipman and Lucie Seyler and has published in prestigious journals such as Nature Communications, Hepatology and Advanced Drug Delivery Reviews.
In The Last Decade
Maya Hites
70 papers receiving 1.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Maya Hites Belgium | 24 | 777 | 629 | 417 | 335 | 302 | 77 | 1.5k | ||
| Paul R. Ingram Australia | 21 | 355 0.5× | 396 0.6× | 393 0.9× | 376 1.1× | 213 0.7× | 61 | 1.4k | ||
| Dimitrios K. Matthaiou Greece | 26 | 580 0.7× | 1.0k 1.6× | 522 1.3× | 1.0k 3.1× | 438 1.5× | 49 | 2.6k | ||
| John Mohr United States | 21 | 378 0.5× | 472 0.8× | 721 1.7× | 287 0.9× | 183 0.6× | 49 | 1.5k | ||
| Eric Wenzler United States | 24 | 636 0.8× | 444 0.7× | 233 0.6× | 872 2.6× | 393 1.3× | 80 | 1.5k | ||
| You-ning Liu China | 27 | 585 0.8× | 857 1.4× | 565 1.4× | 826 2.5× | 189 0.6× | 89 | 2.4k | ||
| Ching‐Chi Lee Taiwan | 27 | 326 0.4× | 904 1.4× | 568 1.4× | 573 1.7× | 333 1.1× | 116 | 2.0k | ||
| Evan J Zasowski United States | 19 | 726 0.9× | 468 0.7× | 883 2.1× | 463 1.4× | 282 0.9× | 49 | 1.6k | ||
| C H Nightingale United States | 26 | 1.2k 1.6× | 962 1.5× | 660 1.6× | 576 1.7× | 205 0.7× | 70 | 2.3k | ||
| Christopher M. Rubino United States | 24 | 1.3k 1.7× | 808 1.3× | 784 1.9× | 807 2.4× | 264 0.9× | 112 | 2.2k | ||
| Sofia K. Kasiakou Greece | 14 | 645 0.8× | 560 0.9× | 136 0.3× | 888 2.7× | 225 0.7× | 16 | 1.4k |
Countries citing papers authored by Maya Hites
Since
Specialization
Citations
This map shows the geographic impact of Maya Hites's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maya Hites with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maya Hites more than expected).
Fields of papers citing papers by Maya Hites
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Maya Hites. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maya Hites. The network helps show where Maya Hites may publish in the future.
Co-authorship network of co-authors of Maya Hites
This figure shows the co-authorship network connecting the top 25 collaborators of Maya Hites. A scholar is included among the top collaborators of Maya Hites based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maya Hites. Maya Hites is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Salvagno, Michele, et al.. (2025). Beta-Lactam Antibiotic Concentrations and the Acquisition of Multi-Drug Resistant Bacteria in Critically Ill Patients. Life. 15(5). 739–739.
2.
Martiny, Delphine, Isabelle Étienne, Delphine Kemlin, et al.. (2024). Monocentric, Retrospective Study on Infectious Complications within One Year after Solid-Organ Transplantation at a Belgian University Hospital. Microorganisms. 12(4). 755–755.
3.
Steenackers, Katie, Nikita Hanning, Liesbeth Bruckers, et al.. (2024). Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial. Vaccine. 42(25). 126117–126117.
4.
Yin, Nicolas, et al.. (2024). Septic arthritis complicating Streptobacillus moniliformis rat bite fever: a case report and review of its pathophysiology and diagnosis. Frontiers in Medicine. 11. 1345354–1345354.
5.
Gaymard, Alexandre, Clément Massonnaud, Nathan Peiffer‐Smadja, et al.. (2024). Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial. Journal of Antimicrobial Chemotherapy. 79(11). 2887–2895.
6.
Mascart, Françoise, Maya Hites, Gil Verschelden, et al.. (2023). Analysis of a Combined HBHA and ESAT-6-Interferon-γ-Release Assay for the Diagnosis of Tuberculous Lymphadenopathies. Journal of Clinical Medicine. 12(6). 2127–2127.
7.
Fougerou‐Leurent, Claire, Christelle Delmas, Juliette Saillard, et al.. (2023). Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20–15 DisCoVeRy study. Contemporary Clinical Trials. 131. 107267–107267.
8.
Taccone, Fabio Silvio, et al.. (2023). Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients. Antibiotics. 12(7). 1099–1099.
9.
Taccone, Fabio Silvio, et al.. (2023). How to Use Nebulized Antibiotics in Severe Respiratory Infections. Antibiotics. 12(2). 267–267.
10.
Lingas, Guillaume, Nadège Néant, Alexandre Gaymard, et al.. (2022). Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial. Journal of Antimicrobial Chemotherapy. 77(5). 1404–1412.
11.
Trøseid, Marius, Maxime Hentzien, Florence Ader, et al.. (2022). Immunocompromised patients have been neglected in COVID-19 trials: a call for action. Clinical Microbiology and Infection. 28(9). 1182–1183.
12.
Taccone, Fabio Silvio, Maya Hites, & Nicolás Dauby. (2022). From hydroxychloroquine to ivermectin: how unproven “cures” can go viral. Clinical Microbiology and Infection. 28(4). 472–474.
13.
Lazarević, Vladimir, Nadia Gaïa, Christiane Knoop, et al.. (2021). Case Report: About a Case of Hyperammonemia Syndrome Following Lung Transplantation: Could Metagenomic Next-Generation Sequencing Improve the Clinical Management?. Frontiers in Medicine. 8. 684040–684040.
14.
Taccone, Fabio Silvio, Elisa Gouvêa Bogossian, Elio Antonucci, et al.. (2020). Early β-lactam concentrations and infectious complications after lung transplantation. American Journal of Transplantation. 21(7). 2489–2497.
15.
Steensels, Deborah, Marijke Reynders, Patrick Descheemaeker, et al.. (2019). Epidemiology and clinical impact of viral, atypical, and fungal respiratory pathogens in symptomatic immunocompromised patients: a two-center study using a multi-parameter customized respiratory Taqman® array card. European Journal of Clinical Microbiology & Infectious Diseases. 38(8). 1507–1514.
16.
Taccone, Fabio Silvio, Jason A. Roberts, Frédérique Jacobs, et al.. (2018). β-Lactam Dosage Regimens in Septic Patients with Augmented Renal Clearance. Antimicrobial Agents and Chemotherapy. 62(9).
17.
Deprez, Guillaume, et al.. (2018). Investigation of unbound colistin A and B in clinical samples using a mass spectrometry method. International Journal of Antimicrobial Agents. 53(3). 330–336.
18.
Roisin, Sandrine, T.-D. Huang, Ricardo De Mendonça, et al.. (2017). Prospective evaluation of a high multiplexing real-time polymerase chain reaction array for the rapid identification and characterization of bacteria causative of nosocomial pneumonia from clinical specimens: a proof-of-concept study. European Journal of Clinical Microbiology & Infectious Diseases. 37(1). 109–116.
19.
Alobaid, Abdulaziz S., Maya Hites, Jeffrey Lipman, Fabio Silvio Taccone, & Jason A. Roberts. (2016). Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review. International Journal of Antimicrobial Agents. 47(4). 259–268.
20.
Hites, Maya, Guillaume Deprez, Fleur Wolff, et al.. (2016). Evaluation of total body weight and body mass index cut-offs for increased cefazolin dose for surgical prophylaxis. International Journal of Antimicrobial Agents. 48(6). 633–640.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Paul R. Ingram Breakdown of academic impact, for papers by Dimitrios K. Matthaiou Breakdown of academic impact, for papers by John Mohr Breakdown of academic impact, for papers by Eric Wenzler Breakdown of academic impact, for papers by You-ning Liu Breakdown of academic impact, for papers by Ching‐Chi Lee Breakdown of academic impact, for papers by Evan J Zasowski Breakdown of academic impact, for papers by C H Nightingale Breakdown of academic impact, for papers by Christopher M. Rubino Breakdown of academic impact, for papers by Sofia K. Kasiakou